Cargando…

Lower airway microbiota in patients with clinically suspected Mycobacterium avium complex lung disease

The relationship between the lower airway microbiota in humans and respiratory illness has gained attention recently. However, the relationship between nontuberculous mycobacterial lung disease (NTM-LD) and the lower airway microbiota is not fully understood yet. We conducted a study to characterize...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasaki, Kotaro, Matsuzawa, Yasuo, Wakabayashi, Hiroki, Shioya, Moe, Hayakawa, Sho, Tatsuno, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214089/
https://www.ncbi.nlm.nih.gov/pubmed/34179537
http://dx.doi.org/10.1016/j.heliyon.2021.e07283
_version_ 1783709988221353984
author Iwasaki, Kotaro
Matsuzawa, Yasuo
Wakabayashi, Hiroki
Shioya, Moe
Hayakawa, Sho
Tatsuno, Ichiro
author_facet Iwasaki, Kotaro
Matsuzawa, Yasuo
Wakabayashi, Hiroki
Shioya, Moe
Hayakawa, Sho
Tatsuno, Ichiro
author_sort Iwasaki, Kotaro
collection PubMed
description The relationship between the lower airway microbiota in humans and respiratory illness has gained attention recently. However, the relationship between nontuberculous mycobacterial lung disease (NTM-LD) and the lower airway microbiota is not fully understood yet. We conducted a study to characterize the lower airway microbiota in Mycobacterium avium complex lung disease (MAC-LD), a representative subclass of the NTM-LD. The subject sample included 25 patients clinically suspected of having mild MAC disease whose condition could not be diagnosed using sputum culture. Upon testing MAC antibodies (anti-glycopeptidolipid (GPL)-core IgA antibodies), mycobacterial culture of bronchoalveolar lavage fluid (BALF), and performing BALF 16S rRNA gene sequencing, we divided the subjects into two groups of patients: those in whom MAC was detected in BALF mycobacterial culture (MAC-LD group) and in whom MAC was not detected in BALF mycobacterial culture (non-MAC-LD group), which was then comparatively examined. BALF mycobacterial culture showed that 9 out of 25 patients were positive for NTM; the detected Mycobacterium was MAC in all. No patients were positive for acid-fast bacteria other than MAC. Eighteen patients were positive for MAC antibodies (anti-glycopeptidolipid (GPL)-core IgA antibodies), including nine patients positive for mycobacterial culture. On BALF 16S rRNA gene sequencing, six patients were positive for the genus Mycobacterium and were culture-positive. Among the 16 patients in the non-MAC-LD group, the genus Pseudomonas was detected by 16S rRNA gene sequencing in 7 patients, 4 among whom were positive for MAC antibodies (anti-GPL-core IgA antibodies). Conversely, the genus Pseudomonas was not detected among the nine patients in the MAC-LD group. Other than the genus Pseudomonas, there was no clear difference in the composition of and no significant difference in the diversity of the bacterial flora between the MAC-LD and non-MAC-LD groups. However, we found that the genus Pseudomonas and MAC tended to exist exclusively.
format Online
Article
Text
id pubmed-8214089
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82140892021-06-25 Lower airway microbiota in patients with clinically suspected Mycobacterium avium complex lung disease Iwasaki, Kotaro Matsuzawa, Yasuo Wakabayashi, Hiroki Shioya, Moe Hayakawa, Sho Tatsuno, Ichiro Heliyon Research Article The relationship between the lower airway microbiota in humans and respiratory illness has gained attention recently. However, the relationship between nontuberculous mycobacterial lung disease (NTM-LD) and the lower airway microbiota is not fully understood yet. We conducted a study to characterize the lower airway microbiota in Mycobacterium avium complex lung disease (MAC-LD), a representative subclass of the NTM-LD. The subject sample included 25 patients clinically suspected of having mild MAC disease whose condition could not be diagnosed using sputum culture. Upon testing MAC antibodies (anti-glycopeptidolipid (GPL)-core IgA antibodies), mycobacterial culture of bronchoalveolar lavage fluid (BALF), and performing BALF 16S rRNA gene sequencing, we divided the subjects into two groups of patients: those in whom MAC was detected in BALF mycobacterial culture (MAC-LD group) and in whom MAC was not detected in BALF mycobacterial culture (non-MAC-LD group), which was then comparatively examined. BALF mycobacterial culture showed that 9 out of 25 patients were positive for NTM; the detected Mycobacterium was MAC in all. No patients were positive for acid-fast bacteria other than MAC. Eighteen patients were positive for MAC antibodies (anti-glycopeptidolipid (GPL)-core IgA antibodies), including nine patients positive for mycobacterial culture. On BALF 16S rRNA gene sequencing, six patients were positive for the genus Mycobacterium and were culture-positive. Among the 16 patients in the non-MAC-LD group, the genus Pseudomonas was detected by 16S rRNA gene sequencing in 7 patients, 4 among whom were positive for MAC antibodies (anti-GPL-core IgA antibodies). Conversely, the genus Pseudomonas was not detected among the nine patients in the MAC-LD group. Other than the genus Pseudomonas, there was no clear difference in the composition of and no significant difference in the diversity of the bacterial flora between the MAC-LD and non-MAC-LD groups. However, we found that the genus Pseudomonas and MAC tended to exist exclusively. Elsevier 2021-06-11 /pmc/articles/PMC8214089/ /pubmed/34179537 http://dx.doi.org/10.1016/j.heliyon.2021.e07283 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Iwasaki, Kotaro
Matsuzawa, Yasuo
Wakabayashi, Hiroki
Shioya, Moe
Hayakawa, Sho
Tatsuno, Ichiro
Lower airway microbiota in patients with clinically suspected Mycobacterium avium complex lung disease
title Lower airway microbiota in patients with clinically suspected Mycobacterium avium complex lung disease
title_full Lower airway microbiota in patients with clinically suspected Mycobacterium avium complex lung disease
title_fullStr Lower airway microbiota in patients with clinically suspected Mycobacterium avium complex lung disease
title_full_unstemmed Lower airway microbiota in patients with clinically suspected Mycobacterium avium complex lung disease
title_short Lower airway microbiota in patients with clinically suspected Mycobacterium avium complex lung disease
title_sort lower airway microbiota in patients with clinically suspected mycobacterium avium complex lung disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214089/
https://www.ncbi.nlm.nih.gov/pubmed/34179537
http://dx.doi.org/10.1016/j.heliyon.2021.e07283
work_keys_str_mv AT iwasakikotaro lowerairwaymicrobiotainpatientswithclinicallysuspectedmycobacteriumaviumcomplexlungdisease
AT matsuzawayasuo lowerairwaymicrobiotainpatientswithclinicallysuspectedmycobacteriumaviumcomplexlungdisease
AT wakabayashihiroki lowerairwaymicrobiotainpatientswithclinicallysuspectedmycobacteriumaviumcomplexlungdisease
AT shioyamoe lowerairwaymicrobiotainpatientswithclinicallysuspectedmycobacteriumaviumcomplexlungdisease
AT hayakawasho lowerairwaymicrobiotainpatientswithclinicallysuspectedmycobacteriumaviumcomplexlungdisease
AT tatsunoichiro lowerairwaymicrobiotainpatientswithclinicallysuspectedmycobacteriumaviumcomplexlungdisease